New regimens as first‐line eradication therapy for <i>Helicobacter pylori</i> infection in patients allergic to penicillin: A randomized controlled trial

Abstract

The efficacies of three bismuth quadruple therapies containing minocycline, cefuroxime, and full-dose metronidazole (pairwise) for first-line H. pylori eradication in penicillin-allergic patients were similarly satisfactory with relatively good safety and compliance. The study was registered in the Chinese Clinical Trials Registration (ChiCTR1900023702).